Back to current studies

Living with relapsing-remitting multiple sclerosis?

NeuroTrials Research is conducting a new research study on the safety & efficacy of a new study drug on subjects with relapsing-remitting Multiple Sclerosis. 

Qualified participants receive all study-related exams and study drug at no cost. Compensation is available for time and travel.

You may qualify if you:

• are 18-65 years old
• have been diagnosed with relapsing-remitting MS
• have NOT relapsed in the past 30 days
• are otherwise in general good health